drugset

drugset / Trial / NCT01528241

Characterize the Regional Distribution of [11C] ABP688 in Brain by Positron Emission Tomography (PET)

NCT01528241 ↗

Phase 1 Completed 42 enrolled Novartis Pharmaceuticals

NaSingle-groupOpen-labelOther

Summary

This study is designed to characterize the regional distribution of \[11C\] ABP688 in brain by positron emission tomography (PET).

Timeline

Start: 2008-08
Primary completion: 2010-05
Completion: 2010-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ABP688	Unknown	—	Intravenous

Indications